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During primary neurogenesis in Xenopus, a cascade of helix–loop–helix (HLH) transcription factors regulates neuronal
determination and differentiation. While XNeuroD functions at a late step in this cascade to regulate neuronal
differentiation, the factors that carry out terminal differentiation are still unknown. We have isolated a new Xenopus
member of the Ebf/Olf-1 family of HLH transcription factors, Xebf3, and provide evidence that, during primary
neurogenesis, it regulates neuronal differentiation downstream of XNeuroD. In developing Xenopus embryos, Xebf3 is
turned on in the three stripes of primary neurons at stage 15.5, after XNeuroD. In vitro, XEBF3 binds the EBF/OLF-1 binding
site and functions as a transcriptional activator. When overexpressed, Xebf3 is able to induce ectopic neurons at neural plate
stages and directly convert ectodermal cells into neurons in animal cap explants. Expression of Xebf3 can be activated by
XNeuroD both in whole embryos and in animal caps, indicating that this new HLH factor might be regulated by XNeuroD.
Furthermore, in animal caps, XNeuroD can activate Xebf3 in the absence of protein synthesis, suggesting that, in vitro, this
regulation is direct. Similar to XNeuroD, but unlike Xebf2/Xcoe2, Xebf3 expression and function are insensitive to
elta/Notch-mediated lateral inhibition. In summary, we conclude that Xebf3 functions downstream of XNeuroD and is
a regulator of neuronal differentiation in Xenopus. © 2001 Academic Press
Key Words: Ebf; Olf-1 homolog; HLH transcription factor; primary neurogenesis; Xenopus laevis.INTRODUCTION
In the past few years, as the molecular mechanisms
underlying neurogenesis have become clearer, it has been
shown that cascades of transcription factors are involved
both in neuronal determination and differentiation. Basic
helix—loop–helix (bHLH) proteins play an important role
in these regulatory cascades (Kageyama and Nakanishi,
1997; Lee, 1997). In Drosophila, the bHLH transcription
factors encoded by the achaete-scute complex (AS-C) and
atonal genes provide cells with the potential to adopt a
neural fate, and thus they have been called “proneural
genes” (Alonso and Cabrera, 1988; Campuzano and Mo-
dolell, 1992; Jarman et al., 1993–1995; Gupta and Ro-
drigues, 1997). In vertebrates, several homologs of AS-C or
atonal have now been identified, such as Mash1, ngn/
Math4, and Math1 in mammals and Xash1, Xash3, Xath1,
Xath5, and X-ngnr-1 in Xenopus laevis (Ferreiro et al., 1992;
Zimmerman et al., 1993; Ma et al., 1996; Sommer et al.,
1 To whom correspondence should be addressed. Fax: 39-02-
26434855. E-mail: g.consalez@hsr.it.
0012-1606/01 $35.00
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All rights of reproduction in any form reserved.1996; Kanekar et al., 1997; Kim et al., 1997; Fode et al.,
1998; Ben-Arie et al., 2000). Evidence that these bHLH
genes promote neurogenesis is provided by overexpression
studies in Xenopus and by targeted gene disruption in
mouse.
During primary neurogenesis in Xenopus laevis, expres-
sion of the bHLH gene neurogenin-related-1 (X-ngnr-1), a
vertebrate neuronal determination gene, defines three ter-
ritories of primary neurogenesis in the developing neural
plate (Ma et al., 1996). Expression of X-ngnr-1 precedes
expression of another bHLH factor, XNeuroD, a regulator of
neuronal differentiation (Lee et al., 1995; Ma et al., 1996).
X-ngnr-1 and XNeuroD function in a unidirectional cascade
to regulate primary neurogenesis. Overexpression of
X-ngnr-1 induces formation of ectopic neurons in nonneu-
ral ectoderm and induces ectopic expression of XNeuroD
(Ma et al., 1996). Similarly, overexpression of XNeuroD is
also able to promote the formation of ectopic neurons (Lee
et al., 1995). These findings suggest that X-ngnr-1 and
XNeuroD function to regulate successive stages of neuronal
differentiation in the developing neural plate. However, the
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496 Pozzoli et al.factors that function downstream of XNeuroD to regulate
neuronal differentiation have not yet been defined.
Neurogenesis in both invertebrates and vertebrates is
negatively regulated through the mechanism of lateral
inhibition. A cell expressing the ligand Delta is able to
activate the receptor Notch in neighboring cells, inhibiting
them from becoming neuronal precursors (Artavanis-
Tsakonas et al., 1995; Lewis, 1996). This cell–cell interac-
tion antagonizes the expression or activity of the proneural
genes through the activation of negative regulatory bHLH
factors such as Enhancer of split (E(Spl)) in Drosophila, or
HES genes in vertebrates (Sasai et al., 1992; Barolo and
Levine, 1997; Bray, 1997; Wettstein et al., 1997). During
primary neurogenesis in Xenopus, activation of the Notch
receptor suppresses neuronal differentiation, in part by
antagonizing X-ngnr-1 activity (Chitnis et al., 1995; Chitnis
nd Kintner, 1996; Ma et al., 1996). In contrast, the activity
f XNeuroD is relatively insensitive to inhibition by Notch
(Chitnis and Kintner, 1996).
It has been recently demonstrated that another gene
family, the Ebf/Olf family, is involved in neurogenesis,
oth in invertebrates and vertebrates (Davis and Reed, 1996;
arel et al., 1999). The EBF transcription factors contain a
LH dimerization domain and a novel zinc finger DNA
inding domain, while they lack the basic region that
ediates the DNA interactions in the bHLH factors. In
itro, these proteins bind an imperfect palindromic DNA
onsensus sequence both as homo- and heterodimers (Hag-
an et al., 1991; Travis et al., 1993; Hagman et al., 1995).
bf (Early B-cell Factor)/Olf-1 (olfactory-neuronal transcrip-
ion factor) was independently cloned in mouse and rat
Hagman et al., 1993; Wang and Reed, 1993). Two other
ouse genes were then identified, Ebf2 (O/E3, Mmot1) and
bf3 (O/E2), along with Xenopus and zebrafish Ebf2 ho-
ologs, Xcoe2 and Zcoe2 (Garel et al., 1997; Malgaretti et
l., 1997; Wang et al., 1997; Bally-Cuif et al., 1998; Dubois
t al., 1998). In addition, members of this family have been
loned in invertebrates: collier, a regulator of anterior head
atterning in Drosophila, and unc3(CeO/E) in C. elegans
Crozatier et al., 1996, 1999; Prasad et al., 1998; Vervoort et
l., 1999).
In the murine neural tube, the Ebf genes are expressed in
he same regions, but Ebf2 is turned on in young postmi-
otic neurons of the subventricular zone, while Ebf1 and
bf3 are expressed in differentiating neurons of the mantle
ayer (Garel et al., 1997; Malgaretti et al., 1997; O.P., L.C.,
nd G.G.C., unpublished results). In Xenopus, Xebf2/Xcoe2
xpression is detected in the three stripes of primary neu-
ons and it is turned on after X-ngnr-1 and before XNeuroD
Dubois et al., 1998). Overexpression of Xebf2/Xcoe2 gives
ise to a nonuniform pattern of ectopic neurons both in the
eural plate and in the presumptive epidermis (Dubois et
l., 1998). Xebf2/Xcoe2 overexpression induces ectopic neu-
ons positive for X-ngnr-1, XDelta-1 (XDl-1), and XNeuroD.
uring normal development, X-ngnr-1 is expressed earlier 2
Copyright © 2001 by Academic Press. All righthan Xebf2/Xcoe2, thus it has been proposed that, in
ebf2/Xcoe2-overexpressing embryos, X-ngnr-1 ectopic ex-
ression results from a positive feedback mechanism
Dubois et al., 1998).
Xebf2/Xcoe2 functions at an early step in the genetic
ascade regulating primary neurogenesis, acting after
-ngnr-1 but before XNeuroD (Dubois et al., 1998). How-
ver, it is still unclear which factors regulate neurogenesis
ownstream of XNeuroD. We describe here a new member
f the Ebf/Olf-1 family, Xebf3, that we propose functions as
regulator of neuronal differentiation in Xenopus. In the
eveloping embryo, Xebf3 expression follows that of XNeu-
oD, and can be activated by overexpression of XNeuroD. In
ddition, Xebf3 can regulate neuronal differentiation since
verexpression of Xebf3 promotes ectopic neurogenesis
oth in whole embryos and in animal cap explants. Simi-
arly to XNeuroD, but unlike Xebf2/Xcoe2, Xebf3 function
ppears to be insensitive to lateral inhibition. Our results
how that Xebf3 is a new regulator of primary neurogenesis
n Xenopus, acting downstream of XNeuroD during neuro-
al differentiation.
MATERIALS AND METHODS
Cloning of Xebf3
The Xebf3 cDNA clone was obtained by screening a stage 28–30
(tailbud tadpole) Xenopus head cDNA library made by Harland
(1991). We used a mouse Ebf2 cDNA probe including the HLH
domain and performed hybridization with low stringency condi-
tions (0.5 M Na2HPO4, 1 mM EDTA, 7% SDS, pH 7.2, at 60°C,
ashes with 40 mM Na2HPO4, 1% SDS, pH 7.2, at RT). For
ositive clones, this was followed by an in vivo excision of the
BlueScript phagemid from the lZAP II vector and by automated
equencing (Primm Labs Sequencing Facility). Sequence analysis
nd contig assembly were performed by using the MacVector
rogram (Oxford Molecular Group) and the Sequencher program
Gene Code Corp.), respectively. The nucleotide sequence of the
argest cDNA clone (2.1 kb), which contained the complete open
eading frame, was deposited into the GenBank database with
ccession number AF040994. With the same screening we also
btained the Xenopus Ebf2 homolog, Xebf2, independently cloned
s Xcoe2 (Dubois et al., 1998).
In Vitro Assays
Electrophoretic mobility shift assay. In vitro transcription
and translation were performed by using the TnT Coupled Reticu-
locyte Lysate Systems (Promega) according to the manufacturer’s
recommendation. The efficiency of in vitro translation was assayed
y running parallel translation reaction performed in the presence
f [35S]methionine (Amersham). The double-stranded synthetic
DNA fragment carrying the binding site for the EBF1 protein
(59-ACCCATGCTCTGGTCCCCAAGGAGCCTGTC-39) (Kudrycki
et al., 1993) and a control DNA fragment where the binding site
had been mutated (59-ACCCATGCTCTGGTCAGCAAGGAGC-
CTGTC-39) were end-labeled with [a-32P]dATP (Amersham) using
0 units of T4 polynucleotide kinase (Ambion). In vitro DNA
s of reproduction in any form reserved.
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497Role of Xebf3 during Neurogenesisbinding and electrophoretic mobility shift assay were performed as
described (Malgaretti et al., 1997). In each binding reaction (20 ml),
e employed 0.15 pmol of labeled doubled-stranded DNA (about
0,000 cpm); 10 ml were then applied to a nondenaturating 6%
polyacrylamide gel.
Luciferase activity assay. NIH3T3 cells were maintained in
Dulbecco’s-modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (Euro Clone), 2 mM L-glutamine (Euro
Clone), 100 IU/ml penicillin, and 100 mg/ml streptomycin. Cal-
cium phosphate-mediated transfection (Di Nocera and Dawid,
1983) was performed in a 60-mm Petri dish with 5 mg of expression
construct, 10 mg of reporter plasmid, and 300 ng of pRL-TK
(Promega) as an internal control. Cells were harvested 60 h after
transfection, lysed, and assayed for luciferase activity (Dual-
Luciferase Reporter Assay System Kit, Promega). All luciferase
assays were performed in triplicate. The pT81-mb1 reporter vector
was composed of a 200-bp DNA fragment of the mb1 promoter
region obtained by PCR amplification with primers mb1-F: 59-
CAGGGATCCATGGTGATGAA-39 and mb1-R: 59-CTCCG-
CCTCACTTCCTGT-39, using mouse genomic DNA as template.
PCR conditions were 3 min at 94°C, 2 min at 80°C in which Pfu
polymerase was added (hot start), followed by 30 cycles of 1 min at
94°C, 1 min at 56°C, 1 min at 72°C, with a final elongation step of
10 min at 72°C. The amplified DNA containing one EBF/OLF-1
binding site, 59-CAAGGGAAT-39 (Hagman et al., 1991), was
cloned into the SmaI site of the pT81 luciferase reporter vector
(Zappavigna et al., 1991), and sequenced (Biostrands).
Microinjection of RNA
The Xebf3 and Xebf2 coding sequences were subcloned into the
StuI site of the expression vector CS21 (Turner and Rupp, 1995)
and were tested by in vitro translation (TnT Coupled Reticulocyte
Lysate System; Promega). The CS21MT-hGR-XNeuroD construct
was generated by amplifying the ligand binding domain of the
human glucocorticoid receptor (hGR) from the plasmid pSP64T-
MyoDGR (Kolm and Sive, 1995), using the forward primer
59-CGCGGATCCGCCATGGCCTCTGAAAATCCTGGTAAC-39
and the reverse primer 59-GCGGCGGGGCATCTAGATTACTTT-
TGATG-39. The PCR product was digested with BamHI and XbaI and
cloned into CS21MT. The XNeuroD coding sequence was cut from
the plasmid CS21MT-XNeuroD with XbaI and subcloned in frame
into the XbaI site of the CS21MT-hGR plasmid. The final construct
was tested by in vitro translation and in vivo for the ability to generate
hormone-dependent ectopic neurons at neural plate stages. Capped
mRNA was transcribed in vitro by using the linearized plasmids
CS21Xebf3, CS21Xebf2, CS21MT-XNeuroD (Lee et al., 1995),
CS21Notch-ICD (Chitnis et al., 1995), CS21X-Delta1stu (Chitnis et
l., 1996), CS21MT-hGR-XNeuroD, and CS21nuclear bgalactosi-
dase (nbgal; Chitnis et al., 1995) as DNA templates (Message Ma-
chine Kit; Ambion).
For two-cell stage experiments, we injected capped mRNA in a
volume of 4 nl into one of the two blastomeres of albino embryos,
using the uninjected side as a control. We used the following RNA
amounts: Xebf3 (0.5 ng), Xebf2 (0.5 ng), XNeuroD (0.5 ng), Notch-
CD (0.1 ng), and nbgal (0.015 ng). The injected embryos were
cultured and staged according to Nieuwkoop and Faber (1994),
fixed in MEMFA (Harland, 1991) for 1 h at room temperature, and
then stored in methanol. X-gal staining was performed on albino
embryos coinjected with nbgal RNA according to Turner andeintraub (1994).
b
Copyright © 2001 by Academic Press. All rightIsolation of Caps, RNA Extraction, and RT-PCR
To isolate animal caps, we injected 4 nl of capped mRNA (Xebf3
0.5 ng, Xebf2 0.5 ng, XNeuroD 0.5 ng, and hGR-XNeuroD 0.8 ng)
nto the animal pole of one-cell stage pigmented embryos. Animal
aps were cut from injected embryos at stage 8 in 13 MMR by
sing the Gastromaster Microsurgery machine (Xenotek Engineer-
ng); the caps were cultured in 13 MMR until control embryos
ere at neural plate stage and then harvested to extract RNA. For
he hormone-inducible XNeuroD experiments, we treated the caps
with 10 uM dexamethasone (Sigma) and 10 uM cycloheximide
(Sigma) as previously described by Gammill and Sive (1997), except
that the caps were cultured in the presence of the protein synthesis
inhibitor for 3 h instead of 5, to increase the viability of the caps. To
test translational inhibition, we incubated the caps in 13 MMR
ontaining 1 mCi/ml of [35S]methionine, according to Gammill and
ive (1997). We observed a translational inhibition .90% in the
aps incubated in the presence of cycloheximide (data not shown).
Total RNA was extracted from harvested animal caps using the
rizol Reagent (Gibco BRL) and then used to perform a reverse
ranscription reaction with oligo-dT12–18 primers. We used the follow-
ing primers, Xebf3 (F: 59-CCTACAAGTCAAAGCAGTTCT-39, R:
59-CCTACTTGGTCATTAGCTTGA-39), Xebf2 (F: 59-GGTATGGA-
GCGAGCTTATCA-39, R: 59-CTGTACAGAGCCTCCGCAAT-39),
N-CAM (F: 59-CACAGTTCCACCAAA TGC-39, R: 59-GGAA-
TCAAGCGGTACAGA-39), N-tubulin (F: 59-ACACGGCATT-
GATCCTACAG-39, R: 59-AGCTCCTTCGGTGTAATGAC-39),
XNF-M (F: 59-CCATCCAGCAGCTGGACAAT-39, R: 59-CTGTCT-
CCTCATCCTCTCCTT-39), XNeuroD (F: 59-GTGAAATCC-
CAATAGACACC-39, R: 59-TTCCCCATATCTAAAGGCAG-39),
Epidermal Keratin (F: 59-CACCAGAACACAGAGTAC-39, R:
59-CAACC TTCCCATCAACCA-39), Muscle actin (F: 59-GCT-
GACAGAATGCAGAAG-39, R: 59-TTGCTTGGAGGAGTGTGT-
39), and EF1a (F: 59-CAGATTGGTGCTGGATATGC-39, R:
9-ACTGCCTTGATGACTCCTAG-39) with these PCR condi-
ions: 39 at 94°C, 28 cycles of 1 min at 94°C, 45 s at 56°C, 1 min at
2°C, and a final elongation step of 59 at 72°C, except for EF1a (19
cycles instead of 28 to stay in the linear range). The RT-PCR were
run on an agarose gel, normalized to EF1a, and acquired with the
Multi-Analyst program.
In Situ Hybridization and Antibody Staining
Antisense RNA probes were generated by in vitro transcription
(T3-T7 MaxiScript Kit; Ambion), and labeled with digoxigenin-11-
UTP (Boehringer Mannheim) for Xebf3 and Xebf2, N-tubulin and
XNF-M, XHox11L2, XPax-2, Xlim-3, and XHoxB9. The Xebf probes
orrespond to the full-length sequences and show 85% identity at
he nucleotide level. The pBlueScript-XNF-M plasmid was gener-
ted by using a forward primer (59-CCATCCAGCAGCT-
GACAAT-39) and a reverse primer (59-CTGTCTCCTCATC-
TCTCCTT-39) to amplify the XNF-M coding region from Xeno-
us total cDNA (stage 40). The PCR product (1 kb) was cloned into
he EcoRV site of pBlueScript SK II (Stratagene).
Whole-mount in situ hybridization was performed on albino
enopus embryos as described by Harland (1991), except that BM
urple (Boehringer Mannheim) was used as the substrate for the
lkaline phosphatase (Kanekar et al., 1997). After in situ hybridiza-
ion, some embryos were cleared using a 2:1 mixture of benzyl
enzoate/benzyl alcohol. Paraffin sections (20 mm) were cut fromstained embryos.
s of reproduction in any form reserved.
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498 Pozzoli et al.FIG. 1. Protein sequence comparison of Xenopus and mouse EBF family of transcription factors. (A) Amino acid sequence alignment of
EBF3, XEBF2, and the three mouse EBF proteins, using the MacVector program. Identical residues are boxed and the DNA binding domain
s indicated by light gray background. In this highly conserved region (.95% identity), which includes a zinc-finger motif (amino acids
51–177), the boxed columns indicate residues important for EBF1 DNA binding and the black dots show the amino acids essential for this
inding (Hagman et al., 1995). These residues are identical in all five EBF proteins. The HLH dimerization domain also shows a very high
evel of homology (.94% identity) and is indicated by dark gray background. (B) Phylogenetic analysis of the EBF factors. The tree was
reated by comparing the protein sequences with the ClustalW method by using the MacVector program.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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clonal antibody (6F11) hybridoma supernatant diluted 1:10, as
FIG. 2. Xebf3 is expressed in the developing Xenopus nervous sy
mbryos by using a digoxigenin-labeled Xebf3 probe. Shown are e
etected at early neural plate stage in the trigeminal placode (st. 1
A: m, medial; i, intermediate; l, lateral). The embryo in (A) is orie
7 embryo, showing Xebf3 expression in the three stripes of primar
he neural tube. In tailbud stage embryos (C–E), Xebf3 was e
(mesencephalon, rhombencephalon, and spinal cord), retina, and ot
benzoate/benzyl alcohol. Abbreviations: ba, branchial arches; ms
rhombencephalon; sc, spinal cord.previously described (Turner and Weintraub, 1994). The primary
Copyright © 2001 by Academic Press. All rightantibody was detected with a horseradish peroxidase-conjugated
sheep anti-mouse antibody (Jackson Laboratories) diluted 1:500,
. Whole-mount in situ hybridization was performed on Xenopus
os at stages 15.5 (A), 17 (B), 24 (C), 28 (D), and 32 (E). Xebf3 was
nd turned on in the three stripes of primary neurons at stage 15.5
with anterior to the top. (B) Posterior transverse section of a stage
rons (m, i, l). At this stage, the neural plate is invaginating to form
ssed in some branchial arches, olfactory placode, neural tube
icle. Embryos in (C—E) were cleared using a 2:1 mixture of benzyl
sencephalon; op, olfactory placode; ov, otic vesicle; r, retina; rh,stem
mbry
3.5) a
nted
y neu
xpre
ic vesfollowed by reaction with diaminobenzidine (DAB).
s of reproduction in any form reserved.
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500 Pozzoli et al.RESULTS
Identification and Expression of Xebf3 in the
Xenopus Embryo
To identify members of the Ebf gene family in Xenopus
aevis, we used a murine Ebf2 cDNA probe spanning the
whole HLH domain to screen a stage 28–30 Xenopus head
DNA library at low stringency. Several positive clones
ere obtained, including a 2.1-kb clone with a complete
pen reading frame encoding a new Xenopus member of the
BF/OLF-1 family. This gene, which we named Xebf3,
ncodes a protein of 598 amino acid residues (Fig. 1A). On
he basis of sequence alignment, this HLH transcription
actor is most closely related to mouse Ebf3 (Fig. 1B). The
ouse EBF3 and the frog protein show 95% identity in the
verall sequence, 97% in the DNA binding domain (amino
cids 51–252), 95% in the HLH domain (amino acids 368–
30), and 90% identity in the C-terminal transactivation
omain (amino acids 431–596).
To define a role for Xebf3 in the developing embryo, we
erformed an analysis of Xebf3 expression by whole-mount
n situ hybridization, showing that Xebf3 is mainly re-
tricted to the nervous system. Xebf3 expression is first
etected at stage 13.5 in the trigeminal placodes (data not
hown), and, at stage 15.5, Xebf3 starts to be expressed in
he neural plate within the three stripes of primary neurons
Figs. 2A and 2B). At neural plate stages, the pattern of
ebf3 expression is similar to that of Xebf2/Xcoe2, which
recedes Xebf3 expression by several hours (Dubois et al.,
1998). At stage 20 (data not shown), Xebf3 continues to be
expressed in the neural tube, olfactory placodes, and is
strongly detected in the cranial neural crest cells. At the
tailbud stage (Fig. 2C), Xebf3 is expressed in the neural tube
and head, in particular in the olfactory placodes and in the
migrating neural crest cells. After their migration, the
cranial neural crest cells contribute to the branchial arches
and their derivatives, mainly to the skeleton of the head and
the cranial ganglia. At stage 28 (Fig. 2D), Xebf3 is detected
in the first three branchial arches, in the olfactory placodes,
in the otic vesicle, and in the neural tube from the midbrain
through the spinal cord. Transverse sections of stained
embryos at this stage reveal that Xebf3 is restricted to the
orsal mantle layer of the neural tube, similar to the
istribution of Xebf2/Xcoe2 (data not shown; Dubois et al.,
998). Around stage 32 (Fig. 2E), Xebf3 maintains this
xpression pattern but is also detected in the retina. At late
tages of development, the pattern of Xebf3 expression is
ery similar to that of Xebf2/Xcoe2; however, Xebf3 is
xpressed in the developing retina while Xebf2 is not, and
hese two genes show different patterns of expression in the
ranchial arches. For probes, we used full-length clones of
ebf2 and Xebf3, which are 85% identical. The different
nsets of expression of the Xebf genes and their similar, but
ot identical, expression patterns during late stages of
evelopment indicate that the two riboprobes do not cross- r
Copyright © 2001 by Academic Press. All righteact. At multiple stages of development, the Xebf3 expres-
ion pattern partially overlaps that of XNeuroD (Lee et al.,
995), in particular in the neural tube (midbrain, hindbrain,
nd spinal cord), in some derivatives of the neural crest,
lfactory placodes, and retina. However, some regions of
he embryo express only XNeuroD and not Xebf3 (pineal
land), while other regions express only Xebf3 and not
NeuroD (some branchial arches). In addition, during late
tages of development, Xebf3 expression is maintained
hile XNeuroD is only transiently expressed in some
ostmitotic neurons (Lee et al., 1995; and data not shown).
XEBF3 Shares the Biochemical Properties of the
Other EBF Proteins
To determine whether XEBF2/XCOE2 and XEBF3 share
the same biochemical functions, we tested their DNA
binding specificity and transactivation activity and we
compared them to those observed for the mouse EBF
proteins, which have been biochemically well characterized
(Travis et al., 1993; Hagman et al., 1995; Wang et al., 1997).
We synthesized the mouse and the Xenopus proteins by in
itro translation and performed a gel mobility shift assay
EMSA), using labeled double-stranded oligonucleotides
epresenting the imperfect palindromic EBF-binding site,
9-ACCCATGCTCTGGTCCCCAAGGAGCCTGTC-39
(Kudrycky et al., 1993). Our results suggest that the Xeno-
us proteins are able to bind the wild-type palindromic
equence as dimers (Fig. 3A) since mouse EBF1 is known to
ind as a dimer (Hagman et al., 1995) and XEBF3 is struc-
urally similar to, and has the same MW as, EBF1. In EMSA
ssays, XEBF3 and EBF1 give rise to gel shift bands of
dentical sizes. This binding is specific since the proteins no
onger bind to a mutated EBF target site (Fig. 3B). In the gel,
e observed a different intensity of the shifted bands due to
different efficiency of in vitro translation of the EBF pro-
eins (data not shown).
Since the EBF transcription factors are highly conserved,
e also tested their ability to activate transcription of a
arget gene in vitro. We cotransfected NIH3T3 cells with an
BF/XEBF expression vector and a reporter plasmid contain-
ng the luciferase gene under the control of a TK basal
romoter and 200 bp of the mb1 distal promoter, which
ontains the imperfect EBF-binding site 59-
AAGGGAAT-39 (Hagman et al., 1991; Travis et al., 1993).
e obtained a high basal value when the reporter plasmid
as transfected alone, due to a low endogenous expression
f Ebf1 in the NIH3T3 cells (data not shown). However, we
bserved a significant activation of the reporter gene with
oth XEBF3 and XEBF2 as well as with mouse EBF2, used as
positive control (Fig. 3C). Although the increases observed
ith the XEBF proteins were always significant, we noticed
hat they were consistently weaker than with mouse EBF2,
robably because these Xenopus transcription factors are
ess efficient in a mouse assay system. In conclusion, our
esults demonstrate that, in vitro, both XEBF3 and XEBF2/
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightXCOE2 show similar DNA binding and transactivation
activity.
Ectopic Expression of Xebf3 Converts Ectodermal
Cells into Neurons
In the molecular cascade regulating primary neurogenesis
in Xenopus, X-ngnr-1 is the first HLH factor to be turned on
and its expression defines the three stripes of primary
neurons (Ma et al., 1996). Temporally, Xebf2/Xcoe2 follows
X-ngnr-1 and precedes XNeuroD activation (Dubois et al.,
998). It has been demonstrated that Xebf2/Xcoe2 overex-
ression promotes ectopic scattered neurogenesis in both
he neural plate and dorsal epidermis (Dubois et al., 1998;
igs. 4E and 4F: N-tubulin, 74% of embryos, n 5 38;
eurofilament-M (XNF-M), 81% of embryos, n 5 18). To
est whether overexpression of Xebf3 is able to induce
ctopic neurons, we injected Xebf3-capped mRNA into one
ell of two-cell stage embryos, using the uninjected side as
n internal control, and we cultured them until neural plate
tage. We performed in situ hybridization experiments and
ounted the percentage of embryos showing ectopic expres-
ion of the neural-specific marker N-tubulin. We observed a
ose-dependent generation of ectopic neurons, mainly re-
tricted to the posterior portion of the presumptive epider-
is and to the lateral stripe (69%, n 5 47; Fig. 4C, and data
not shown). This result was confirmed by using another
neural-specific marker, neurofilament-M, which starts to be
expressed in the developing embryo at stage 19 (XNF-M,
89%, n 5 19; Fig. 4D, and data not shown). In both cases,
the ectopically activated neural markers were expressed in
a scattered cell pattern. Interestingly, we observed that
XNF-M was much more robustly activated than N-tubulin
and it was strongly present throughout the injected side of
the embryo before its normal onset of expression. In mouse,
the neurofilament-M promoter contains a presumptive EBF-
binding site (A.B. and G.G.C., unpublished), therefore this
strong ectopic expression in Xebf3-injected embryos might
reflect a direct activation of neurofilament-M by Xebf3.
Xebf3-injected embryos stained at stage 28 with an anti-N-
CAM antibody showed that some of these epidermal cells
differentiated into process-bearing neurons (Fig. 4G, arrow-
XEBF3. A total of 10 mg of the luciferase reporter plasmid pT81
ither containing (mb1) or lacking (pT81) the mb1 promoter
sequence was cotransfected into the cells to monitor transactiva-
tion activity of the expressed proteins. In all of the samples, 300 ng
of pRL-TK was transfected as an internal control. The graph is
labeled so that, for each bar, the expression plasmid is listed first
and the reporter plasmid is listed last (e.g., EBF2-mb1). Values
indicate the mean of the results from three independent experi-
ments and all of the columns indicated by an asterisk (*) are
statistically different from control luciferase values (*, P , 0.0002;FIG. 3. XEBF3 binds the EBF/OLF-1 binding site and can activate
transcription in vitro. The DNA binding and transactivation activi-
ties of XEBF3 and XEBF2/XCOE2 were compared to the mouse EBF
proteins. (A, B) Gel mobility shift assay showing specific affinity of
the EBF/XEBF factors for the EBF/OLF-1 palindromic binding site.
Blank, no lysate; RRL, rabbit reticulocyte lysate only; other lanes,
in vitro-synthesized, unlabeled EBF/XEBF proteins. All of the
reactions were incubated with [a-32P] end-labeled double-stranded
oligonucleotide containing either a wild-type or mutated EBF/
OLF-1 binding site derived from the OMP (Olfactory Marker
Protein) promoter and then run on a nondenaturating polyacryl-
amide gel. A shifted band was observed after the incubation of all
of the EBF/XEBF proteins with the wild-type binding site (A), but
not with a mutated site (B). (b) Indicates the shifted bands and (f) the
free probe. (C) Luciferase assay revealing the different levels of
transactivation activity of the EBF family members. Luciferase
activity was measured in luciferase units and was assayed from
lysates of NIH3T3 cells. The cells were transfected with 5 mg of**, P , 0.001 by Student’s t-test).
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502 Pozzoli et al.heads). Analysis of Xebf3-injected embryos using markers
for specific neuronal subtypes indicated that Xebf3 induced
ectopic expression of XHox11L2 (87%, n 5 21; Fig. 4H), a
cranial sensory ganglia and Rohon–Beard neurons marker
(Patterson and Krieg, 1999), but did not induce the expres-
sion of XHoxB9 (Saha et al., 1997) and Xlim3 (Taira et al.,
1993), which identify primary motor neurons starting at
early tailbud stage (data not shown). Similarly, we did not
observe ectopic activation of the interneuron marker Pax2
(Heller and Brandli, 1997, and data not shown). These
results suggest that Xebf3 promotes differentiation of spe-
cific neuronal subtypes which show the characteristics of
sensory neurons.
To confirm that Xebf3 overexpression is sufficient to
convert nonneuronal cells (epidermis) into neurons, we
injected Xebf3 mRNA into one-cell stage embryos, isolated
animal caps at midblastula stage (stage 8), and cultured
them until control embryos were at neural plate stage. In
both the Xebf3- and Xebf2/Xcoe2-injected animal caps, we
observed activation of the neural-specific markers N-CAM
(Kintner and Melton, 1987), N-tubulin, and XNF-M by
RT-PCR (Fig. 4I). XNeuroD-injected caps were used as a
positive control. There was no evidence for activation of the
mesodermal marker muscle actin, demonstrating that the
neuralization of these caps was direct. These results show
that Xebf3 is able to induce neurogenesis and to convert
ectodermal cells into neurons both in vivo and in animal
caps.
In Vivo, XNeuroD Activates Expression of Xebf3
but Not of Xebf2/Xcoe2
It has been shown that X-ngnr-1 strongly activates Xebf2/
Xcoe2, which turns on XNeuroD and also maintains
X-ngnr-1 expression through a positive feedback mecha-
nism (Dubois et al., 1998, and Figs. 5F and 5G: X-ngnr-1,
FIG. 4. Xebf3 and Xebf2/Xcoe2 overexpression promotes ectopic e
njected into one cell of two-cell stage Xenopus embryos, and then
nalysis, using the probes indicated at the top. Shown are dorsal
njected side, revealed by X-gal staining, to the right. (A, B) Control
n developing primary neurons, while XNF-M is normally express
ebf2/Xcoe2 (E, F) promoted ectopic neurogenesis, as detected by w
probe. Embryos injected with either Xebf3 or Xebf2/Xcoe2 show
posterior ectoderm (C, E) compared with the more extensive and st
28 Xebf3-injected embryo immunostained with the anti-N-CAM
ectopic process-bearing neurons. (H) Xebf3-overexpressing cells sho
of a stage 26 Xebf3 overexpressing embryo with the injected side
activation of XHox11L2, a late marker of cranial sensory ganglia an
from embryos at stage 8 and cultured to neural plate stage. Overexp
expression of N-CAM, a marker of undifferentiated neural tissue, N
of mesodermal factors (muscle actin). Caps isolated from bgal- an
respectively (lanes 1 and 4). An additional positive control is repre
lane 5). Epidermal keratin was used as a marker for epidermis, and Elo
Copyright © 2001 by Academic Press. All right2%, n 5 23; XNeuroD, 68%, n 5 19). These results suggest
that Xebf2/Xcoe2 is involved in primary neurogenesis and
promotes neuronal differentiation by activating XNeuroD.
Because XNeuroD is turned on before Xebf3 and after
Xebf2/Xcoe2, we analyzed the effects of the ectopic XNeu-
roD expression on both Xebf3 and Xebf2/Xcoe2 expression.
XNeuroD mRNA was injected into embryos at the two-cell
stage, and the embryos were cultured and then collected at
neural plate stage. Overexpression of XNeuroD caused
ectopic expression of Xebf3 (78%, n 5 29), while Xebf2/
Xcoe2 was not activated (100%, n 5 22; Figs. 5A and 5B).
This result and the fact that Xebf3 expression temporally
follows and partially overlaps that of XNeuroD suggest that
Xebf3 could be a transcriptional target of XNeuroD. Over-
expression of Xebf2/Xcoe2 promoted the activation of
XNeuroD (68%, n 5 19; Figs. 5G and 5M) and also of Xebf3
(76%, n 5 23; Figs. 5H and 5M), but not vice versa (Figs. 5D,
5E and 5L; XNeuroD, 91%, n 5 31; Xebf2/Xcoe2, 84%, n 5
38).
To confirm that overexpression of XNeuroD causes acti-
vation of Xebf3, we performed animal cap experiments. In
these assays, we used RNA extracted from uninjected total
embryos harvested at stage 18 as a positive control. We
observed a strong ectopic activation of Xebf3 and an inter-
esting weak activation of Xebf2/Xcoe2 in caps isolated from
XNeuroD-injected embryos compared to bgal-injected con-
rol caps (Fig. 5I). Our in vivo data also suggested that Xebf2
ould activate expression of XNeuroD and Xebf3, while
ebf3 could not activate XNeuroD or Xebf2. To confirm
these regulatory relationships, we performed animal cap
experiments and observed that Xebf3 overexpression did
not promote ectopic activation of Xebf2 or XNeuroD (Fig.
L), while caps isolated from Xebf2-injected embryos
howed ectopic expression of both Xebf3 and XNeuroD (Fig.
5M), similar to what is observed in vivo. In summary, our
gain-of-function results and the sequential onset of expres-
sion of neural markers in vivo and in animal caps. (A—F) RNA was
ryos were collected at neural plate stages for in situ hybridization
s of representative embryos with anterior to the bottom and the
yos injected with RNA for b-galactosidase. N-tubulin is expressed
ter, starting at stage 19. (C—F) Overexpression of Xebf3 (C, D) or
-mount in situ hybridization using an N-tubulin probe or a XNF-M
scattered pattern of N-tubulin-positive neurons restricted to the
er distribution of ectopic XNF-M-positive neurons (D, F). (G) Stage
ody 6F11 (enlargement of the ventral side). Arrowheads indicate
aracteristics of sensory neurons. Dorsal view (anterior to the left)
icated by X-gal staining. Overexpression of Xebf3 caused ectopic
hon–Beard neurons. (I) RT-PCR performed on animal caps isolated
on of either Xebf3 or Xebf2/Xcoe2 (lanes 2 and 3) promoted ectopic
lin and XNF-M, markers of differentiating neurons, in the absence
euroD-injected embryos served as negative and positive controls,
d by RNA extracted from total embryos at neural plate stage (TE,xpres
emb
view
embr
ed la
hole
ed a
rong
antib
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ind
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ressi
-tubu
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sentengation factor1a (EF1a) served as a loading control.
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(504 Pozzoli et al.FIG. 5. Xebf2/Xcoe2, XNeuroD, and Xebf3 function in a unidirectional cascade during primary neurogenesis. Embryos were injected with
RNA for XNeuroD (A, B), Xebf3 (C–E), and Xebf2 (F–H) at the two-cell stage and then assayed by whole-mount in situ hybridization at
neural plate stages. Embryos are shown in a dorsal view with anterior to the bottom and injected side to the right (marked by X-gal staining).
Overexpression of XNeuroD promoted ectopic expression of Xebf3 (A), while it suppressed the expression of Xebf2/Xcoe2 (B).
Overexpression of Xebf3 did not affect Xngnr-1, XNeuroD, and Xebf2/Xcoe2 expression patterns (C–E), while Xebf2/Xcoe2-injected
embryos showed ectopic expression of Xngnr-1, XNeuroD, and Xebf3 (F-H). (I–M) RT-PCR performed on animal caps isolated from
XNeuroD (I), Xebf3 (L), or Xebf2/Xcoe2 (M) -injected embryos. The overexpression of XNeuroD caused a strong ectopic activation of Xebf3
(I, lane 2). Note that, in these caps, XNeuroD induced a very weak expression of Xebf2/Xcoe2 (I, lane 2). Overexpression of Xebf3 did not
induce the expression of Xebf2 or XNeuroD (L, lane 2). In contrast, Xebf2-injected caps showed the activation of XNeuroD as well as Xebf3
(M, lane 2). Caps isolated from bgal-injected embryos and RNA extracted from total embryos (TE) served as negative and positive controls
lanes 1 and 3). Muscle actin was used as a mesodermal marker, and EF1a was used to normalize the samples.
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505Role of Xebf3 during Neurogenesission of these HLH factors demonstrate that Xebf3 functions
ownstream of XNeuroD in the molecular cascade that
egulates neuronal differentiation in Xenopus.
Xebf3 Expression Can Be Directly Activated by
hGR-XNeuroD in Animal Cap Explants
Our results show that Xebf3 is turned on in the neural
late after XNeuroD and that overexpression of XNeuroD
ctivates ectopic Xebf3, both in vivo and in animal cap
xplants. To determine whether Xebf3 is a direct target of
NeuroD in vitro, we constructed a hormone-inducible
NeuroD fusion protein by adding the ligand-binding do-
ain of the human glucocorticoid receptor (hGR) to the
NeuroD coding region (hGR-XNeuroD). To test the func-
ion of hGR-XNeuroD, we injected capped mRNA into one
lastomere of two-cell stage embryos and assayed for the
ormation of ectopic N-tubulin positive cells by whole-
ount in situ hybridization. We observed extensive ectopic
xpression of N-tubulin in the injected side in embryos
reated with dexamethasone, while no ectopic neurons
ere detected in the injected embryos incubated without
he hormone (Hutcheson and Vetter, 2001). If Xebf3 is a
irect target of XNeuroD in vitro, it should be activated by
GR-XNeuroD in the absence of protein synthesis. To test
his, we injected hGR-XNeuroD RNA into one-cell stage
igmented embryos and cut animal caps at stage 8. The caps
ere then pretreated for 30 min with cycloheximide, an
nhibitor of protein synthesis, then cultured with or with-
ut dexamethasone and cycloheximide for 2.5 h (Gammill
nd Sive, 1997). To verify the block of protein synthesis,
ome of the caps were assayed for the incorporation of
35S]methionine. We observed greater than 90% transla-
tional inhibition in the caps incubated in the presence of
cycloheximide (data not shown). The caps were then har-
vested to extract total RNA and the expression of Xebf3 was
ssayed by RT-PCR. We observed a significant activation of
ebf3 expression when hGR-XNeuroD was activated by
examethasone both in the presence and absence of protein
ynthesis (Fig. 6, lanes 1 and 2), while no activation of Xebf3
as detected without the hormone (Fig. 6, lanes 3 and 4).
his suggests that the transcriptional regulation of Xebf3
y hGR-XNeuroD is direct. To further ensure that we had
ffectively inhibited protein synthesis with CHX, we as-
ayed for activation of XNF-M expression by hGR-
NeuroD. We found that XNF-M was activated only in the
resence but not in the absence of protein synthesis (Fig. 6,
anes 1 and 2) demonstrating that, in contrast to Xebf3,
NF-M is only indirectly regulated by XNeuroD. We nor-
alized the level of Xebf3 and XNF-M expression by testing
he ubiquitous EF1a transcript. To confirm these results
and ensure that we were in the linear range of PCR, we
performed RT-PCR with different cycle numbers, then
quantitated the amplification after blotting the amplified
bands and hybridizing with a radioactive probe. We ob-
served again a significant expression of Xebf3 in the caps
Copyright © 2001 by Academic Press. All rightreated with dexamethasone, both in the presence and
bsence of protein synthesis (data not shown). We also
ested whether Xebf2 could directly activate Xebf3 in
nimal caps. By using a similar hormone-inducible fusion
onstruct, Xebf2-hGR (O.P. and G.G.C., unpublished), we
bserved that Xebf2 activated Xebf3 in animal caps, but
hat this activation was eliminated when protein synthesis
as blocked with cycloheximide, demonstrating that the
egulation was indirect (data not shown). These results
emonstrate that Xebf3 acts downstream of XNeuroD dur-
ng neuronal differentiation in Xenopus and that in vitro
GR-XNeuroD activates Xebf3 directly in the absence of
protein synthesis.
Delta/Notch-Mediated Lateral Inhibition Does Not
Block the Function of Xebf3
In both invertebrates and vertebrates, the cascade of HLH
transcription factors regulating neurogenesis is strictly
regulated by Delta/Notch-mediated lateral inhibition. This
cell–cell interaction mechanism is important for selecting
FIG. 6. Xebf3 expression in animal caps can be activated by
GR-XNeuroD in the absence of protein synthesis. RT-PCR on
nimal caps isolated from hGR-XNeuroD-injected embryos,
reated with or without dexamethasone (DEX) and/or cyclohexi-
ide (CHX), an inhibitor of protein synthesis. Hormone-dependent
ctivation of injected hGR-XNeuroD promoted ectopic expression
of Xebf3, both in the absence and presence of protein synthesis
(lanes 1 and 2), while activation of XNF-M expression was only
observed in the presence (lane 2) but not the absence of protein
synthesis (lane 1). Xebf3 and XNF-M expression were not induced
in the absence of dexamethasone (lanes 3 and 4). TE (lane 5)
indicates total embryo at stage 14, and B (lane 6) is a blank in which
template was excluded from the PCR. Muscle actin is a mesoder-
mal marker, and EF1a was used as a loading control.the cells that will take on the neural fate, and prevents
s of reproduction in any form reserved.
e
t
s
b
a
d
b
a
d
X
s
e
l
r
i
a
i
X
N
R
o
s
X
e
n
1
a
p
w
s
p
a
7
i
I
p
(
7
e
m
i
n
a
n
s
B
t
p
m
t
a
t
t
a
r
n
s
w
T
s
X
r
a
s
e
w
506 Pozzoli et al.surrounding cells from becoming neurons (Artavanis-
Tsakonas et al., 1995; Lewis, 1996). It has been shown that
the function as well as the expression of X-ngnr-1 is
sensitive to lateral inhibition (Ma et al., 1996) and overex-
pression of X-ngnr-1 promotes ectopic neurogenesis in a
scattered pattern due to the action of the lateral inhibition
pathway (Ma et al., 1996). Xebf2/Xcoe2, which is activated
by X-ngnr-1, controls the transition between neural compe-
tence and irreversible commitment, and, at the same time,
promotes neuronal differentiation (Dubois et al., 1998).
Xebf2/Xcoe2 also promotes neurogenesis in a scattered
pattern when overexpressed, and coinjection of Xebf2/
Xcoe2 with X-Dl1stu causes an increase in the density of
ctopic neurons induced by Xebf2/Xcoe2, suggesting that
he ability of Xebf2/Xcoe2 to promote neurogenesis is
ensitive to lateral inhibition (Dubois et al., 1998). It has
een shown that both X-ngnr-1 and Xebf2/Xcoe2 are able to
ctivate expression of XNeuroD, a regulator of neuronal
ifferentiation (Ma et al., 1996; Dubois et al., 1998). Em-
ryos coinjected with both XNeuroD and Notch-ICD RNA,
constitutively active form of Notch, show the same
istribution of ectopic neurons as those injected with
NeuroD alone (Chitnis and Kintner, 1996). This result
uggests that the ability of XNeuroD to promote neurogen-
sis is resistant to lateral inhibition and is probably modu-
ated by other regulatory mechanisms, even though XNeu-
oD itself is able to induce X-Delta-1 and activate lateral
nhibition (Chitnis and Kintner, 1996).
If Xebf3 is functioning downstream of XNeuroD, then the
ctivity of Xebf3 should similarly be insensitive to lateral
nhibition. We therefore tested whether the activity of
ebf3 could be inhibited by coexpression with activated
otch. Two-cell stage embryos were injected with Xebf3
NA (500 pg), Notch-ICD RNA (100 pg), or a combination
f both and assayed by in situ hybridization at neural plate
tages for expression of the neural markers N-tubulin and
NF-M. The embryos injected with Notch-ICD showed the
xpected block in primary neurogenesis (N-tubulin, 76%,
5 17; and had no effect on XNF-M expression (Fig 7C)
00%, n 5 15; Fig. 7D), while embryos injected with Xebf3
lone produced ectopic scattered neurons both in the neural
late and epidermis (Figs. 4C and 4D). Embryos injected
ith both Notch-ICD and Xebf3 RNA and assayed by in i
Xebf2/Xcoe2-positive neurons within the three stripes of primary
XneuroD-injected embryos, overexpression of XNeuroD promoted ecto
Copyright © 2001 by Academic Press. All rightitu hybridization for N-tubulin and XNF-M gave the same
attern of ectopic neurons as those injected with Xebf3
lone (N-tubulin, 66%, n 5 29; XNF-M, 86%, n 5 30; Figs.
E and 7F), showing that Xebf3 is resistant to lateral
nhibition. We also coinjected some embryos with Notch-
CD and Xebf2/Xcoe2 RNA (500 pg) and observed a com-
lete inhibition of neurogenesis in the majority of embryos
N-tubulin, 77%, n 5 27; XNF-M, 83%, n 5 35; Figs. 7G and
H). In the remainder of the cases, we found a very weak
ctopic expression of both N-tubulin and XNF-M that was
uch more restricted than that observed in the embryos
njected with Xebf2/Xcoe2 alone (data not shown). We did
ot see any difference in potency by injecting different
mounts of RNA (Xebf3 300 pg, Xebf2/Xcoe2 800 pg; data
ot shown), confirming that Xebf2/Xcoe2 function is sen-
itive to lateral inhibition, while Xebf3 function is not.
ecause we show that both Xebf3 and XNeuroD are resis-
ant to lateral inhibition, but Xebf3 induces a scattered
attern of ectopic neurons, it is possible that Xebf3 is
odulated by other regulatory factors that may act during
he late stages of neuronal differentiation.
In almost all of the embryos injected with XNeuroD and
ssayed by in situ hybridization, we noticed a downregula-
ion of Xebf2/Xcoe2 expression (Fig. 5B; 77%, n 5 26). To
est whether this downregulation is due to the ectopic
ctivation of lateral inhibition induced by exogenous XNeu-
oD, we coinjected two-cell stage embryos with the domi-
ant negative form of Delta, X-Dlstu, either alone or in
combination with XNeuroD. Overexpression of X-Dl1stu
caused an increase in Xebf2/Xcoe2 expression within the
three stripes of primary neurons (Fig. 7L; 94%, n 5 18),
while Xebf3 expression was not influenced (Fig. 7I; 100%,
n 5 20). The block of lateral inhibition in XNeuroD-
overexpressing embryos promoted ectopic activation of
Xebf2/Xcoe2 both in the neural plate and epidermis (Fig.
7N; 92%, n 5 24), while the level of Xebf3 ectopic expres-
ion was not affected, compared to the embryos injected
ith XNeuroD alone (Figs. 5A and 7M; 76%, n 5 25).
herefore, the expression of Xebf2/Xcoe2, but not Xebf3, is
ensitive to inhibition by Notch ensuring that in vivo
ebf3, but not Xebf2/Xcoe2, is activated by XNeuroD. This
esult might also explain our observation that Xebf2/Xcoe2
s weakly activated in caps isolated from XNeuroD-injectedFIG. 7. Xebf3 is insensitive to Delta/Notch-mediated lateral inhibition mechanism. Embryos were injected with RNA at the two-cell
stage then collected at neural plate stages and assayed by in situ hybridization for expression of the neural markers N-tubulin and XNF-M,
nd of Xebf3 and Xebf2/Xcoe2, as indicated at the top. Injected embryos are oriented with their anterior side down (dorsal view, injected
ide revealed by X-gal staining). Overexpression of an activated form of the Notch receptor (Notch-ICD) caused a suppression of N-tubulin
xpression (C) and no change in XNF-M expression (D) on the injected side. XNF-M is normally turned on at stage 19. Embryos coinjected
ith Notch-ICD and Xebf3 (E, F) gave a similar pattern of ectopic N-tubulin and XNF-M expression as with Xebf3 alone (see Figs. 4C and
4D), suggesting that Xebf3 function was not inhibited by activated Notch. In contrast, embryos coinjected with Notch-ICD and
Xebf2/Xcoe2 showed an inhibition of neurogenesis (G, H), as compared with embryos injected with Xebf2/Xcoe2 alone (Figs. 4E and 4F).
The block of the Delta/Notch pathway induced by injecting X-Dl1stu did not influence Xebf3 expression (I) but caused an increase in theneurons (L). When lateral inhibition was similarly blocked in
pic expression of both Xebf3 and Xebf2/Xcoe2 (M, N).
s of reproduction in any form reserved.
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508 Pozzoli et al.embryos (Fig. 5I). It is possible that activation of the lateral
inhibition pathway in isolated ectodermal explants is not as
robust as in vivo or that mosaic inheritance of XNeuroD
sets up a nonuniform lateral inhibitory mechanism where
previously there was none, resulting in detectable activa-
tion of Xebf2/Xcoe2 in XNeuroD-injected caps. Our find-
ings show that the sequential expression of these HLH
proteins, in combination with the action of the lateral
inhibition pathway, ensure that the molecular cascade that
regulates primary neurogenesis in Xenopus is unidirec-
tional, and that Xebf3 functions downstream of XNeuroD.
DISCUSSION
Xebf3 Is Structurally and Functionally Related to
Other Members of the Ebf/Olf-1 Family
In Xenopus laevis, primary neurogenesis is controlled by
a unidirectional cascade of HLH transcription factors that
regulate neural determination and differentiation. In the
last few years, multiple proteins in this pathway have been
identified and analyzed on the basis of their activities and
mutual interactions (Kageyama and Nakanishi, 1997; Lee,
1997). In the present paper, we describe the cloning of
Xebf3, a new member of the Ebf/Olf-1 family of HLH
transcription factors, and analyze its role in this regulatory
cascade. Xebf3 is most closely related to mouse Ebf3, a gene
expressed in late differentiating neurons in the mantle layer
of the developing neural tube (Garel et al., 1997). Pairwise
sequence comparisons indicate that Xebf3 is also closely
related to Ebf2 (Garel et al., 1997; Malgaretti et al., 1997;
Wang et al., 1997) and to its X. laevis ortholog, Xebf2/Xcoe2
(Dubois et al., 1998), as well as to mouse Ebf1 (Hagman et
al., 1993), another gene expressed in differentiating neu-
rons, for which no amphibian ortholog has been found to
date. In vitro, XEBF3, like XEBF2/XCOE2, binds the recog-
nition sequence of rat OLF-1, an imperfect palindromic
sequence found in several olfactory gene promoters
(Kudrycky et al., 1993). The same recognition sequence is
bound by all three murine Ebf genes (Wang et al., 1997).
Likewise, we demonstrate with luciferase reporter assays
that XEBF3, like XEBF2/XCOE2, is a transcriptional activa-
tor. Therefore, XEBF3 shares several important biochemical
properties with other members of the EBF family of tran-
scription factors.
Xebf3 Functions as a Regulator of Neuronal
Differentiation
In the developing Xenopus embryo, Xebf3 is expressed in
ifferentiating primary neurons of the neural tube as well as
n other parts of the developing nervous system. Xebf3
xpression is detected in the three stripes of primary neu-
ons at stage 15.5, which is after the onset of XNeuroD (Lee
t al., 1995), suggesting a putative role for Xebf3 in regulat-
ng late steps of neuronal differentiation. In Xenopus em- e
Copyright © 2001 by Academic Press. All rightryos, overexpression of Xebf3 leads to ectopic expression
f the neuronal markers N-CAM, N-tubulin, and
eurofilament-M, demonstrating the ability of Xebf3 to
romote neuronal differentiation.
In animal caps cut from Xebf3-injected embryos, the
ame neuronal markers are activated, confirming the ability
f Xebf3 to convert ectodermal cells into neurons. The lack
f activation of the mesodermal marker muscle actin indi-
ates that the neuralizing effect of Xebf3 is direct and
ndependent of mesodermal signals. Therefore, Xebf3
hares one fundamental property with bHLH factors such as
-ngnr-1 and XNeuroD, namely the ability to promote
FIG. 8. Model describing the transcriptional interactions of the
molecular cascade that controls primary neurogenesis during Xe-
nopus development, modified from Dubois et al. (1998). The
components of the original model from Dubois et al. (1998) are
shown in black, while the additions to the model provided by this
study are shown in red. This model shows the sequential activation
of X-ngnr-1, Xebf2/Xcoe2, XNeuroD, and Xebf3 in the three stripes
of primary neurons. The expression of the proneural gene X-ngnr-1
in neuronal precursors causes the activation of Xebf2/Xcoe2, which
regulates the first steps of neuronal differentiation by inducing the
expression of XNeuroD. Xebf3 functions downstream of XNeuroD
at a later stage of neuronal differentiation and is able to promote,
directly or indirectly, the activation of late neuronal differentiation
markers. The expression and function of X-ngnr-1 and Xebf2/Xcoe2
are sensitive to Delta/Notch-mediated lateral inhibition, which
negatively regulates the first stages of neurogenesis. XNeuroD
expression, but not function, can be inhibited by Notch, while
Xebf3 expression and function are both insensitive to Notch
regulation. Our data show that, in vitro, XNeuroD can activate
ebf3 as well as Xebf2/Xcoe2, but, in vivo, this step is blocked by
lateral inhibition (red dotted arrow), ensuring the molecular path-
way of HLH transcription factors functions as a unidirectional
cascade. The different level of ectopic neurogenesis induced by
Xebf3 and XNeuroD and their partially overlapping expression
patterns suggest that Xebf3 is only one of the potential downstream
ffectors of XNeuroD.ctopic neurogenesis when overexpressed, and the ability to
s of reproduction in any form reserved.
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509Role of Xebf3 during Neurogenesisdirectly neuralize animal cap tissue (Lee et al., 1995; Ma et
l., 1996). However, Ebf genes are structurally unrelated to
these proneural bHLH transcription factors and the onset of
Xebf3 expression during Xenopus primary neurogenesis
uggests that it plays its primary role at a step subsequent to
hat of the bHLH genes. Furthermore, XNeuroD is still able
o promote ectopic N-tubulin activation when coinjected
ith a dominant negative form of Xebf3 lacking the DNA
inding domain (data not shown), confirming that Xebf3 is
ot required for early steps of neurogenesis. The overexpres-
ion of this Xebf3 dominant negative construct does cause
reduction of the endogenous expression of XNF-M (data
ot shown), so it is possible that Xebf3 is instead required
or later steps in neuronal differentiation. Similarly, in
ouse, all of the Ebf genes are activated in postmitotic
ayers of the embryonic neural tube (Garel et al., 1997;
algaretti et al., 1997), and likely control neuronal differ-
entiation, rather than regulating the onset of neurogenesis.
Outside of the neural plate, Xebf3 is expressed at high
levels in developing sensory tissues (trigeminal, otic and
olfactory placodes, cranial neural crest) and, at the tailbud
stage, in the dorsal neural tube. In addition, we find that
Xebf3 overexpression ectopically activates XHox11L2 ex-
pression, a late marker of cranial and Rohon–Beard neurons,
but does not induce motor neuron or interneuron markers.
This evidence suggests that Xebf3 overexpression is suffi-
cient to promote differentiation of sensory neurons in vivo,
while not ruling out a possible contribution of this gene to
the establishment or maturation of other neural lineages. It
has been shown that the bHLH factor X-ngnr-1 controls
neural determination during primary neurogenesis and sub-
sequently contributes to the specification of sensory iden-
tity (Fode et al., 1998; Olson et al., 1998; Perron et al.,
1999). Likewise, our data suggest that Xebf3 might regulate
some aspects of sensory neuron differentiation, likely at a
later step in this cascade.
How is Xebf3 regulating neuronal differentiation? Since
Xebf3 is a transcriptional activator it might directly regu-
late the expression of late neuronal differentiation genes.
Overexpression of Xebf3 by RNA injection induces a strong
and widespread expression of the neuronal differentiation
marker XNF-M throughout the ectoderm on the injected
side. The ectopic expression is detected prior to the onset of
normal XNF-M expression in the embryo. In mouse, the
NF-M promoter contains potential EBF/OLF-1 binding sites
(A.B. and G.G.C., unpublished results), suggesting that in
Xenopus there may be a direct activation of XNF-M by
Xebf3. In addition, in rat and mouse olfactory epithelium,
EBF1/OLF-1 can directly regulate the transcription of mul-
tiple olfactory-specific genes, such as G(olf), OMP (Olfac-
tory Marker Protein), and olfactory receptor genes, that
directly contribute to the differentiated phenotype of olfac-
tory receptor neurons (Kudrycky et al., 1993; Wang et al.,
1993).In addition, more indirect mechanisms may contribute to
Copyright © 2001 by Academic Press. All rightthe regulation of neuronal differentiation by Xebf3. A
30-zinc finger DNA binding protein named ROAZ was
identified as a physical interactor and transcriptional cofac-
tor of EBF/OLF-1 in rat olfactory neurons (Tsai and Reed,
1997). ROAZ interacts with all three murine members of
the EBF family in vitro (Tsai and Reed, 1998). Recently, it
has been shown that ROAZ cooperates with SMAD pro-
teins, which are important for transducing BMP2/4 signal-
ing into the nucleus (Hata et al., 2000). In Xenopus, XOAZ
binds SMAD proteins involved in BMP2/4 signaling and
may be a bifunctional partner of both SMAD and XEBF
proteins. The Xoaz transcript is ubiquitous in the develop-
ing embryo until late neural plate stages, after which it
becomes restricted to the anterior neural tube. When over-
expressed, the XEBF proteins may compete with SMAD
proteins for association with the common cofactor XOAZ
and may thus antagonize BMP signaling at the intracellular
level. Such an antagonistic interaction between the Ebf and
BMP networks could play a crucial role later in nervous
system development since BMP signaling affects neural
cell-type specification and differentiation (Liem et al., 1997;
LaBonne and Bronner-Fraser, 1998; Alder et al., 1999; Barth
et al., 1999; Nguyen et al., 2000). For example, BMPs have
been shown to inhibit neurogenesis in cultures from olfac-
tory epithelium (Shou et al., 1999) and to affect the differ-
entiation of neural stem cells in the adult CNS (Lim et al.,
2000). However, antagonism of BMP signaling alone is
extremely unlikely to account for the specific ability of
Xebf3 to promote XNF-M gene expression and sensory
neuron differentiation. Further studies are required in order
to test whether this mechanism plays a role in the ability of
Xebf3 to promote neurogenesis.
Xebf3 Functions Downstream of XNeuroD
Our results show that Xebf3 functions downstream of
XNeuroD and that the hormone-inducible form of XNeu-
roD (hGR-XNeuroD) directly activates the expression of
Xebf3 in vitro. In addition, overexpression of X-ngnr-1,
Xebf2/Xcoe2, or XNeuroD is able to activate Xebf3 expres-
ion, but not vice versa, confirming that the regulatory
ascade of HLH transcription factors that controls primary
eurogenesis in Xenopus is unidirectional. In particular,
ctivation of the lateral inhibition pathway by XNeuroD
nsures that Xebf3, but not Xebf2, is normally activated in
vivo downstream of XNeuroD. Based on our results, we
propose a model in which Xebf3 is turned on after the
sequential activation of X-ngnr-1, Xebf2/Xcoe2, and XNeu-
roD (Fig. 8). However, the robust ectopic activation of
Xebf2/Xcoe2 as a result of XNeuroD overexpression and
inhibition of Notch signaling raises questions on the rela-
tive position of Xebf2/Xcoe2 within the neurogenetic cas-
cade. In fact, Xebf2/Xcoe2 might lie downstream of XNeu-
roD in that pathway and the activation of XNeuroD by
Xebf2/Xcoe2 may possibly stem from a positive feedback
mechanism.
s of reproduction in any form reserved.
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510 Pozzoli et al.Xebf3 is likely not the exclusive factor functioning down-
stream of XNeuroD. When Xebf3 is overexpressed, we
observe a more restricted pattern of ectopic neurons,
mainly confined to the posterior part of the embryo, than
that induced by overexpression of XNeuroD. It is possible
that, in the same neurons, XNeuroD activates, directly or
indirectly, multiple factors, including Xebf3, that interact
to regulate neuronal differentiation. Another possibility is
that Xebf3 functions downstream of XNeuroD only in some
neurons, which are differentiating toward a particular phe-
notype. In support of the latter hypothesis, the expression
patterns of Xebf3 and XNeuroD overlap only in some
regions of the developing embryo and the overexpression of
Xebf3 promotes ectopic activation of the sensory-specific
gene XHox11L2.
Xebf3 and Xebf2/Xcoe2 Have Different Functions
during Neurogenesis in Xenopus
In this paper, we demonstrate that XEBF3 and XEBF2/
XCOE2 show similar DNA binding and transactivation
activity in vitro. Nevertheless, several lines of evidence
support the idea that XEBF3 and XEBF2/XCOE2 have dif-
ferent functions in vivo. First, the two Xebf genes are
turned on at different times in the developing embryo.
Xebf2/Xcoe2 is activated earlier, at stage 12.5, in the three
stripes of primary neurons, when the transition between
neural competence and irreversible commitment occurs
(Dubois et al., 1998). In contrast, Xebf3 is activated later in
the neural plate, at stage 15.5, while the primary neurons
are differentiating. This is in agreement with observations
made in the mouse neural tube, where Ebf2 is expressed in
early postmitotic neurons of the subventricular zone, while
Ebf1 and Ebf3 are expressed in more differentiated neurons
f the mantle layer (Garel et al., 1997). Second, Xebf2/
Xcoe2 functions downstream of X-ngnr-1 (Dubois et al.,
1998), while our results show that Xebf3 acts downstream
of XNeuroD. The above differences likely reflect the exis-
tence of distinct cis-acting regulatory sequences, driving
expression of the two genes at different times and under
control of different factors in the genetic cascade regulating
neurogenesis.
Our results strongly indicate that additional differences
between Xebf3 and Xebf2/Xcoe2 exist, and that the two
enes, although closely related, encode proteins endowed
ith intrinsically distinct functional properties. For ex-
mple, overexpression of Xebf2/Xcoe2 activates expression
f XNeuroD (Dubois et al., 1998), while Xebf3 does not,
onsistent with their roles at different steps of primary
eurogenesis. In addition, the ability of Xebf2/Xcoe2 to
romote the formation of ectopic neurons is sensitive to
nhibition by activated Notch, while Xebf3 function in this
ssay is insensitive to inhibition. This suggests that Xebf2/
coe2, unlike Xebf3, is inhibited by Notch activation in the
ame cell, besides possibly triggering lateral inhibition in
eighboring ones, and that Xebf2/Xcoe2 is not only inhib-
Copyright © 2001 by Academic Press. All rightted at the transcriptional level, but also posttranscription-
lly. One hypothesis is that Xebf2/Xcoe2 function may be
epressed by a Notch-activated cofactor that interacts with
EBF2/XCOE2 but not with XEBF3. The differential inter-
ction of Xebf3 and Xebf2/Xcoe2 with the Notch signaling
athway might translate into distinct functional properties
f the Ebf genes during early and late differentiation.
The mechanisms underlying the key functional differ-
nces observed between Xebf3 and Xebf2/Xcoe2 are not
lear. A comparison of XEBF3 and XEBF2/XCOE2 protein
equences reveals that the greatest discrepancies between
he two closely related proteins reside in the putative
rotein–protein interaction domain, located in the
-terminal region of EBF proteins (Tsai and Reed, 1997). It
s therefore possible that XEBF3 and XEBF2/XCOE2 inter-
ct with different cofactors that confer distinct functional
roperties upon these proteins. In contrast, the highest
egree of similarity is found in the DNA binding domain, in
eeping with our gel mobility shift data.
In conclusion, we have cloned and characterized Xebf3, a
ew member of the Ebf/Olf-1 transcription factors family.
ur work clarifies the unique role of Xebf3 downstream of
NeuroD as a regulator of neuronal differentiation during
rimary neurogenesis in Xenopus. In addition, these results
emonstrate that the two Xenopus members of this family,
ebf3 and Xebf2/Xcoe2, have distinct functions and that
hey interact with different components of the pathway
egulating neuronal differentiation. The emerging proper-
ies of the Ebf genes should warrant their recognition as key
egulators of vertebrate neural development.
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